Lanean...
Changes in B and T lymphocytes and chemokines with rituximab treatment in multiple sclerosis
BACKGROUND: B cells are implicated in the pathogenesis of multiple sclerosis (MS). A beneficial effect of B cell depletion using rituximab has been shown, but the complete mechanism of action for this drug is unclear. OBJECTIVE: To determine the relationship between T cells, B cells, and changes in...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2918395/ https://ncbi.nlm.nih.gov/pubmed/20558389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.99 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|